A bite-sized insight into our successful BioSeed event
Innovative Biotech and Medtech Startups Shine at BioSeed 2025
The 11th annual BioSeed event brought together 42 pioneering biotech and medtech companies to present their ground-breaking technologies to an audience of over 100 active life sciences investors. Throughout the day, C-suite leaders showcased solutions to a range of conditions impacting quality of life as well as life-threatening diseases, both rare and prevalent affecting global populations. This included new targets and treatment methods, innovative medical devices, diagnostics and surgical solutions. They also featured novel and repurposed small molecule drugs, biologics, blood monitoring, engineering and cryopreservation techniques.
The event concluded with a networking drinks reception, providing attendees the opportunity to build valuable connections and celebrate the day’s successes. A highlight of the evening was the announcement of the BioSeed session winners:
- Session 1: Ryan Lafferty, Dia Beta Labs
- Session 2: Sam Windsor, Ignota Labs
- Session 3: Alice Preston, Panthura
- Session 4: Rob Chisholm, ReForm Therapeutics
- Session 5: Liza Levy, Unravel Health
- Session 6: Rod Lane, myRipple
The overall BioSeed 2025 Winner was Alice Preston, CEO of Panthura—a well-deserved recognition of her company’s cutting-edge contributions to the industry.
We extend our congratulations to all speakers for their insightful presentations and commend their dedication to shaping the future of life sciences.
As we look ahead, we are thrilled to invite you to our next major event—BioTrinity 2025. For more details or to register, please contact us at events@obn.org.uk or click here to grab yourself a ticket.